塞鼻通膠囊

Country: Taiwan

Language: Chinese

Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Active ingredient:

CARBINOXAMINE MALEATE;;CAFFEINE ANHYDROUS;;PHENYLPROPANOLAMINE HCL (DL-NOREPHEDRINE HCL);;LYSOZYME (CHLORIDE);;GLYCYRRHIZINIC ACID (EQ TO GLYCYRRHETINIC ACID GLYCOSIDE)(EQ TO GLYCYRRHIZIC ACID )

Available from:

晉安製藥股份有限公司 嘉義縣民雄鄉雙福村建國路３段２６０巷９號 (65607901)

ATC code:

R05X

Pharmaceutical form:

膠囊劑

Composition:

CARBINOXAMINE MALEATE (0400000610) 4MG; PHENYLPROPANOLAMINE HCL (DL-NOREPHEDRINE HCL) (1212002410) 25MG; CAFFEINE ANHYDROUS (2820000450) 40MG; LYSOZYME (CHLORIDE) (4400091310) (12.5MG)10MG; GLYCYRRHIZINIC ACID (EQ TO GLYCYRRHETINIC ACID GLYCOSIDE)(EQ TO GLYCYRRHIZIC ACID ) (9200004600) 15MG

Units in package:

瓶裝

Class:

製　劑

Prescription type:

須經醫師指示使用

Manufactured by:

皇佳化學製藥股份有限公司 高雄縣烏松鄉松埔路１巷１號 TW

Therapeutic area:

OTHER COLD PREPARATIONS

Therapeutic indications:

感冒諸症狀（流鼻水、鼻塞、打噴嚏、喀痰）

Product summary:

註銷日期: 2009/12/30; 註銷理由: 屆期未申請展延; 有效日期: 2005/05/25; 英文品名: SAPITON CAPSULES "C.A."

Authorization status:

已註銷

Authorization date:

1983-02-10